covicis Publications

Our Scientific Publications

Partnership for Public Health Emergencies Preparedness & Response Seeks 1 Billion USD | Africa CDC and WHO Strengthen Efforts to Safeguard Africa’s Health

European Commission designates first European reference laboratories for public health

EU pledges support for African Union disease control and prevention

COVICIS NEWS​ FEBRUARY 2024

As CoVICIS enters its third year of implementation, the CoVICIS study teams continue conducting cutting edge research in Europe and sub-Saharan Africa on SARS-CoV-2 and its implications for infectious disease, key populations and possible future pandemics.

CoVICIS Newsletter​ September 2023

Launched in early 2022, CoVICIS represents a global approach to combatting the SARS-CoV-2 pandemic, coupling powerful state-of-the-art virologic and immunologic platforms with large genomic surveillance studies and diverse cohorts in Europe and sub-Saharan Africa (SSA).

CoVICIS in context: surveillance and Switzerland with Prof. Milo Puhan, MD, Ph.D., University of Zurich

Professor Puhan joins us to discuss the three prospective cohort studies, including children, adolescents, and adults, based at EBPI that are contributing to the CoVICIS project.

Interview with Giuseppe Pantaleo, Horizon Magazine

Professor Giuseppe Pantaleo spoke with Vittoria D’Alessio from Horizon Magazine to discuss the ongoing work of researchers to monitor populations for new variants of concern. The article features a profile of CoVICIS and the EU-funding COVIRNA project which is devising a test to predict who is most likely to develop cardiovascular complications.

CoVICIS Newsletter​ November 2022

Launched in early 2022, CoVICIS represents a global approach to combatting the SARS-CoV-2 pandemic, coupling powerful state-of-the-art virologic and immunologic platforms with large genomic surveillance studies and diverse cohorts in Europe and sub-Saharan Africa (SSA).

CoVICIS in context: surveillance and South Africa with Prof. Carolyn Williamson, Ph.D., University of Cape Town​

Prof Williamson joins us to discuss the impressive surveillance work being conducted in South Africa and some of the insights into future work to investigate the role of the HIV epidemic in the emergence of variants of concern.